| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | Director | Common Stock | 99.5K | $298K | $3.00 | Jun 11, 2025 | Direct |
| Aquestive Therapeutics, Inc. | Director | Stock Option (Right to Purchase) | 42K | $143K | $3.41 | Jun 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Jun 11, 2025 | 1 | $143K | 4 | Jun 12, 2025 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| AQST | Aquestive Therapeutics, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
| AQST | Aquestive Therapeutics, Inc. | May 10, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |